JP2017526916A5 - - Google Patents

Download PDF

Info

Publication number
JP2017526916A5
JP2017526916A5 JP2017507713A JP2017507713A JP2017526916A5 JP 2017526916 A5 JP2017526916 A5 JP 2017526916A5 JP 2017507713 A JP2017507713 A JP 2017507713A JP 2017507713 A JP2017507713 A JP 2017507713A JP 2017526916 A5 JP2017526916 A5 JP 2017526916A5
Authority
JP
Japan
Prior art keywords
cancer
prl3
patient
sample
exosomes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2017507713A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017526916A (ja
Filing date
Publication date
Priority claimed from SG10201404895XA external-priority patent/SG10201404895XA/en
Application filed filed Critical
Publication of JP2017526916A publication Critical patent/JP2017526916A/ja
Publication of JP2017526916A5 publication Critical patent/JP2017526916A5/ja
Withdrawn legal-status Critical Current

Links

JP2017507713A 2014-08-13 2015-08-13 癌の診断 Withdrawn JP2017526916A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG10201404895X 2014-08-13
SG10201404895XA SG10201404895XA (en) 2014-08-13 2014-08-13 Diagnosis
PCT/SG2015/050259 WO2016024918A1 (en) 2014-08-13 2015-08-13 Diagnosis of cancer

Publications (2)

Publication Number Publication Date
JP2017526916A JP2017526916A (ja) 2017-09-14
JP2017526916A5 true JP2017526916A5 (enExample) 2018-09-13

Family

ID=55304429

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017507713A Withdrawn JP2017526916A (ja) 2014-08-13 2015-08-13 癌の診断

Country Status (6)

Country Link
US (1) US20170234880A1 (enExample)
EP (1) EP3189333A4 (enExample)
JP (1) JP2017526916A (enExample)
CN (1) CN106716132A (enExample)
SG (2) SG10201404895XA (enExample)
WO (1) WO2016024918A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10874610B2 (en) 2016-10-19 2020-12-29 Northwestern University Extracellular vesicle-based diagnostics and engineered exosomes for targeted therapeutics against cancer
CN107058556A (zh) * 2017-05-09 2017-08-18 大连海事大学 一种用于评估硫丹促癌风险的方法
CN110613727B (zh) * 2017-12-11 2022-06-21 浙江大学 NK细胞外泌体hsa-miR-9502在抗菌中的应用
CN110531082A (zh) * 2018-05-25 2019-12-03 国家纳米科学中心 用于乳腺癌检测及分子分型的外泌体检测装置和应用
US20230266323A1 (en) * 2020-08-06 2023-08-24 Lsi Medience Corporation Diagnosis method for bladder cancer
CN112698033A (zh) * 2020-12-09 2021-04-23 复旦大学附属中山医院 一种血源性外泌体her2的检测方法及其应用
CN118376789B (zh) * 2024-06-25 2024-09-13 南昌大学第一附属医院 一种用于诊断肺癌的检测试剂盒及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1848742A1 (en) * 2005-01-28 2007-10-31 Attogen, Inc. Anti-prl-3 antibodies and methods of use thereof
DK3360571T3 (da) * 2007-05-03 2021-01-04 Agency For Science Tech And Research Astarstar Antistoffer, der binder til et intracellulært PRL-1- eller PRL-3-polypeptid
CN107254538A (zh) * 2008-11-12 2017-10-17 卡里斯生命科学瑞士控股有限责任公司 使用外来体来确定表现型的方法和系统
GB0822836D0 (en) * 2008-12-15 2009-01-21 Oxford Biomedica Ltd Method
CN108434440B (zh) * 2011-09-06 2022-08-23 新加坡科技研究局 多肽疫苗

Similar Documents

Publication Publication Date Title
JP2017526916A5 (enExample)
Hoseok et al. Lung cancer biomarkers
Harouaka et al. Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications
RU2018101257A (ru) Способ детекции нуклеосом, содержащих гистоновые варианты
PH12020551371A1 (en) Assays to detect neurodegeneration
MX374652B (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco.
WO2014140933A3 (en) Method for the prognosis and treatment of cancer metastasis
EA201792497A1 (ru) Антитела к gitr для диагностики злокачественной опухоли
JP2017538669A5 (enExample)
BR112015021199A2 (pt) método para determinar se uma infeção é bacteriana e/ou viral, dispositivo de fluxo lateral para detecção de um analito em uma amostra, e, dispositivo para detecção de um marcador bacteriano e/ou viral em uma amostra
JO3681B1 (ar) استخدام مجموعات الجين الطافر fgfr في الكشف عن مرضى السرطان الذين سوف يستجيبون للعلاج بمثبط fgfr
BR112014006741A2 (pt) método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial
JP2017503481A5 (enExample)
MX2019005683A (es) Metodos para detectar mutaciones de adn mediante el uso de extraccion con puntas mitra.
EP3495502A3 (en) Biomarkers for premature birth
HK1232238A1 (zh) 检测人类骨膜蛋白的新型测定
JP2017505897A5 (enExample)
Costa et al. Diagnosis of human strongyloidiasis: Application in clinical practice
WO2009111254A3 (en) A rapid and sensitive method for quantitative determination of the level of heparin-pf4 complex induced immunoglobulin antibodies
JP2018155752A5 (enExample)
PH12019500675A1 (en) Methods of diagnosing and treating abiraterone acetate- glucocorticoid -resistant or -sensitive metastatic castration resistant prostate cancer
JP2017524933A5 (enExample)
RU2016135933A (ru) Композиция для противоракового вспомогательного лекарственного средства, содержащая средство, индуцирующее экспрессию rip3, в качестве активного ингредиента, способ скрининга противоракового вспомогательного лекарственного средства, повышающего чувствительность к противораковому лекарственному средству путем стимуляции экспрессии rip3, и способ контроля чувствительности к противораковому лекарственному средству
EP4057007A3 (en) Method for the diagnosis of breast cancer
RU2016102202A (ru) Биологический маркер опухоли